Multiple Myeloma Management - Partners in Practice with Dr. Ajai Chari Team from UCSF
From Oncology Brothers: Practice-Changing Cancer Discussions · · 21 min
This plays from the publisher's own server. We do not host a copy.
Description
Welcome to the Oncology Brothers podcast! In this episode of our Partners in Practice series, we dived into the world of multiple myeloma treatment. We had the opportunity to engage with the dedicated team from UCSF, including Dr. Ajai Chari, a myeloma specialist, nurse practitioner Samantha Shenoy, NP, and clinical nurse Jenny Truong, RN.
In this insightful discussion, we covered:
- The current standard of care for newly diagnosed multiple myeloma patients, focusing on quadruple therapy
- The role of anti-CD38 therapies like daratumumab and isatuximab in treatment regimens
- Patient expectations regarding side effects and the importance of supportive care
- The dynamics of teamwork in oncology, emphasizing communication and collaboration among healthcare professionals
Whether you're a healthcare professional, a patient, or simply interested in the latest advancements in cancer care, this episode offers valuable insights into the complexities of treating multiple myeloma.
Listen us on:
Spotify: https://open.spotify.com/show/31BXhY9FM4gPWG10WgE11o
Follow us on social media:
- X/Twitter: https://x.com/oncbrothers
- Instagram: https://www.instagram.com/oncbrothers
- Website: https://oncbrothers.com/
Don't forget to like, subscribe, and hit the notification bell for more episodes from the Oncology Brothers!
#MultipleMyeloma, #QuadTherapy, #Daratumumab, #Isatuximab, #OncologyBrothers
Back to Oncology Brothers: Practice-Changing Cancer Discussions · Report a problem